Clinical Flow Cytometry, a Hypothesis-Driven Discipline of Modern Cytomics

Cytometry Part A

Volumn 58, Issue 1, 2004, Pages 87-97

  Janossy, George ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ACUTE LYMPHOCYTIC LEUKEMIA; B LYMPHOCYTE; CELL IMMORTALIZATION; CELL LINEAGE; CELL SELECTION; CELL STRUCTURE; COMPUTER ASSISTED DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTORY OF MEDICINE; HUMAN; HYBRIDOMA; HYPOTHESIS; LABORATORY TEST; LEUKEMIA; MICROSCOPY; MINIMAL RESIDUAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS;

EID: 1542619409     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20011     Document Type: Review

References (62)

1. Shapiro H. Practical flow cytometry. 4th ed. New York: Wiley-Liss; 2003.
2. Keating P Cambrosio A. Biomedical platforms-realigning the normal and the pathological in late-twentieth-century medicine. Cambridge: MIT Press; 2003.
3. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001;291:1304-1351.
4. LaBaer J. Genomics, proteomics, and the new paradigm in biomedical research. Genet Med 2002;4:2S-9S.
5. Lefkovits I. Functional and structural proteomics: a critical appraisal. J Chromatogr B Analyt Technol Biomed Life Sci 2003;787:1-10.
6. Valet G. Past and present concepts in flow cytometry: a European perspective. J Biol Regul Homeost Agents 2003;17:213-222.
7. Valet GK, Tarnok A. Cytomics in predictive medicine. Cytometry 2003;53B:1-3.
8. Best Pract Res Clin Haematol 2002;15.
9. Best Pract Res Clin Haematol 2003;16.
10. Janossy G, Jani, IV, Brando, B. New trends in affordable CD4+ T-cell enumeration by flow cytometry in HIV/AIDS. Clin Appl Immunol Rev 2003;4:91-107.
11. Brouet JC, Valensi F, Daniel MT, Flandrin G, Preud'homme JL, Seligmann M. Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients. Br J Haematol 1976;33:319-328.
12. Salmon SE, Seligmann M. B-cell neoplasia in man. Lancet 1974;2: 1230-1233.
13. Brown G, Capellaro D, Greaves M. Leukemia-associated antigens in man. J Natl Cancer Inst 1975;55:1281-1289.
14. Greaves M, Janossy G. Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta 1978;516:193-230.
15. Newman RA, Sutherland R, Greaves MF. The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors. J Immunol 1981;126:2024-30.
16. Bernard A BL, Dausset J, Milstein C, Schlossman SF, editors. Leucocyte typing I. Berlin: Springer Verlag; 1984.
17. Janossy G, Roberts M, Greaves MF. Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia. Lancet 1976;2:1058-61.
18. Greaves MF. 'Target' cells, differentiation and clonal evolution in chronic granulocytic leukaemia: a 'model' for understanding the biology of malignancy. In: Chronic granulocytic leukaemia. London: Praeger Publishers; 1982. p 15-47.
19. Janossy G, Woodruff RK, Paxton A, Greaves MF, Capellaro D, Kirk B, et al. Membrane marker and cell separation studies in Ph1-positive leukemia. Blood 1978;51:861-877.
20. Janossy G, Goldstone AH, Capellaro D, Greaves MF, Kulenkampff J, Pippard M, et al. Differentiation linked expression of p28,33 (Ia-like) structures on human leukaemic cells. Br J Haematol 1977;37:391-402.
21. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
22. Parks DR, Bryan VM, Oi VT, Herzenberg LA. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci USA 1979;76:1962-1966.
23. Dangl JL, Parks DR, Oi VT, Herzenberg LA. Rapid isolation of cloned isotype switch variants using fluorescence activated cell sorting. Cytometry 1982;2:395-401.
24. Schlossman SF, Reinherz EL, Nadler L, editors. Leucocyte typing II. Berlin: Springer Verlag; 1986.
25. Loken MR, Lanier LL. Three-color immunofluorescence analysis of Leu antigens on human peripheral blood using two lasers on a fluorescence-activated cell sorter. Cytometry 1984;5:151-158.
26. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987; 69:255-263.
27. Loken MR, Shah VO, Hollander Z, Civin CI. Flow cytometric analysis of normal B lymphoid development. Pathol Immunopathol Res 1988; 7:357-370.
28. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987;70:1316-1324.
29. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 1990;4: 657-663.
30. Strobl H, Takimoto M, Majdic O, Fritsch G, Scheinecker C, Hocker P, et al. Myeloperoxidase expression in CD34+ normal human hematopoietic cells. Blood 1993;82:2069-2078.
31. Scheinecker C, Strobl H, Fritsch G, Csmarits B, Krieger O, Majdic O, et al. Granulomonocyte-associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells. Blood 1995;86:4115-4123.
32. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991; 77:1218-1227.
33. Bofill M, Janossy G, Janossa M, Burford GD, Seymour GJ, Wernet P, et al. Human B cell development. II. Subpopulations in the human fetus. J Immunol 1985;134:1531-1538.
34. Campana D, Coustan-Smith E, Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990;76:163-171.
35. Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B- ALL. Leukemia 1999;13:419-427.
36. Campana D, Coustan-Smith E. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002;15:1-19.
37. Vidriales MB, San-Miguel JF, Orfao A, Coustan-Smith E, Campana D. Minimal residual disease monitoring by flow cytometry. Best Pract Res Clin Haematol 2003;16:599-612.
38. Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96:2691-2696.
39. Gratama JW, D'Hautcourt J L, Mandy F, Rothe G, Barnett D, Janossy G, et al. Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry 1998;33:166-178.
40. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 1996;26:137-147.
41. Bikoue A, Janossy G, Barnett D. Stabilised cellular immuno-fluorescence assay: CD45 expression as a calibration standard for human leukocytes. J Immunol Methods 2002;266:19-32.
42. Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS immune monitoring scheme. Cytometry 1996;26:216-22.
43. Janossy G, Jani I, Gohde W. Affordable CD4(+) T-cell counts on 'single-platform' flow cytometers I. Primary CD4 gating. Br J Haematol 2000;111:1198-1208.
44. Ortolani C, Forti E, Radin E, Cibin R, Cossarizza A. Cytofluorimetric identification of two populations of double positive (CD4+,CD8+) T lymphocytes in human peripheral blood. Biochem Biophys Res Commun 1993;191:601-609.
45. Lavabre-Bertrand T, Janossy G, Exbrayat C, Bourquard P, Duperray C, Navarro M. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL. Leukemia 1994;8:1557-1563.
46. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425-1431.
47. Didier JM, Kazatchkine MD, Demouchy C, Moat C, Diagbouga S, Sepulveda C, et al. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr 2001;26:193-195.
48. Mandy F, Nicholson J, Autran B, Janossy G. T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle. Cytometry 2002;50:39-45.
49. Bergeron M, Nicholson JK, Phaneuf S, Ding T, Soucy N, Badley AD, et al. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry 2002; 50:53-61.
50. Glencross DK, Scott LE, Jani IV, Barnett D, Janossy G. CD45 assisted PanLeucogating for accurate, affordable dual platform CD4+ T cell enumeration. Commun Clin Cytometry 2002;50:69-77.
51. Janossy G, Jani W, Kahan M, Barnett D, Mandy F, Shapiro H. Precise CD4 T-cell counting using red diode laser excitation: For richer, for poorer. Cytometry 2002;50:78-85.
52. Paxton H, Pins M, Denton G, McGonigle AD, Meisner PS, Phair JP. Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology. Clin Diagn Lab Immunol 1995;2:104-114.
53. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med 1989;169:327-332.
54. Loua A, Kestens L, Vanham G, Boel L, Colebunders R, Gigase P. [Validity of an ELISA test for CD4+ T lymphocyte count and validity of total lymphocyte count in the assessment of immunodeficiency status in HIV infection]. Ann Soc Belg Med Trop 1994;74:61-68.
55. Mason D. Leucocyte typing VII. Oxford: Oxford University Press; 2003.
56. De Rosa SC, Roederer M. Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. Clin Lab Med 2001;21:697-712.
57. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003;101: 2711-2720.
58. Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA 1991;88:5528-5532.
59. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002;39:537-545.
60. Mandy FF, Nakamura T, Bergeron M, Sekiguchi K. Overview and application of suspension array technology. Clin Lab Med 2001;21: 713-729.
61. Jani W, Janossy G, Brown DW, Mandy F. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002;2:243-250.
62. Bradley NJ, Jani, IV, Mandy F, Janossy G. Single platform flow cytometry in HIV infection: multitasking and multiplexing for lymphocyte subsets, haematological differential counts and serological status. Cytometry 2004; in press.